Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Quang X. Pham, serving as both Chief Executive Officer and Chairman of Cadrenal Therapeutics, Inc. (NASDAQ: CVKD), has executed a series of stock sales totaling $36,209. These transactions occurred over a three-day period from June 3 to June 5, 2026, with prices ranging between $4.26 and $4.42 per share. The sales were conducted under a Rule 10b5-1…
Farmers & Merchants Bancorp Inc. (NASDAQ:FMAO) director Andrew J. Briggs executed a sale of 3,000 shares on June 5, 2026, totaling $83,430 at a price of $27.81 per share. Following the transaction, Briggs retains a direct holding of 201,550 shares. The sale occurs as FMAO shares have gained 27% over the past year and trade near InvestingPro's fair …
ImmunityBio, Inc. (NASDAQ: IBRX) director Simon Barry J. completed a sale of 23,033 common shares on June 4, 2026, generating approximately $165,305 in proceeds. The transaction was structured under a pre-arranged Rule 10b5-1 trading plan adopted in December 2025. This sale occurs against a backdrop of substantial year-to-date stock appreciation, t…
Maya Prosor, Chief Business Officer at Lemonade, Inc. (NASDAQ:LMND), executed a sale of company equity on June 3, 2026, generating $64,867 in proceeds. The transaction involved the liquidation of 1,220 shares at $53.17 each. This disposition was necessitated by tax withholding requirements associated with the vesting and settlement of Restricted St…
Yu Jiang, President and Chairman of Nano Nuclear Energy Inc. (NASDAQ:NNE), executed a significant divestiture of common stock on June 3, 2026, selling approximately $19.9 million worth of shares. The transactions were facilitated through a Rule 10b5-1 trading plan established in September 2025. This insider activity takes place while NNE shares are…
Gen Digital Inc. (NASDAQ:GEN) director John C. Chrystal acquired 3,000 shares of the company's common stock on June 4, 2026, at a price of $27.057 per share, totaling $81,171. Following the transaction, Chrystal directly holds 31,419 shares of Gen Digital common stock. The filing also disclosed his direct ownership of 51,140 Contingent Value Rights…
John Sheldon Peters, Lemonade's Chief Insurance Officer, executed two separate sales of company stock this week totaling $283,257. The transactions occurred against a backdrop of an 11% weekly decline in Lemonade's share price, bringing the current valuation to $51.46. While the sales were driven by tax obligations and a pre-arranged trading plan, …
Timothy Bixby, Chief Financial Officer of Lemonade, Inc. (NASDAQ:LMND), executed a transaction involving the sale of 2,227 shares of the company's common stock on June 3, 2026. The transaction, valued at $118,409, involved shares sold at an average price of $53.17 each. This activity was not discretionary but was necessitated by tax withholding obl…
Jacqueline M. Welch, Executive Vice President and Chief Human Resources Officer at The New York Times Company (NYSE:NYT), sold 4,000 shares of the company’s Class A Common Stock on June 3, 2026. The transaction, valued at $296,548, occurred at prices ranging from $74.130 to $74.180 per share, with a weighted average price of $74.137. Following the …
Jaisun Garcha, Chief Financial Officer at Nano Nuclear Energy Inc. (NASDAQ: NNE), executed a series of stock sales totaling approximately $985,617 on June 3, 2026. The transactions were conducted under a Rule 10b5-1 trading plan established in September 2025, involving the disposal of 37,215 shares at prices ranging from $25.71 to $29.91. This dive…
Nano Nuclear Energy Inc. (NASDAQ: NNE) reported a recent insider transaction following a Form 4 filing, wherein Chief Technology Officer Florent Heidet sold 3,000 shares of common stock totaling $74,857. The sale occurred on June 5, 2026, with shares trading between $24.8500 and $25.0850 per share. This transaction follows the vesting of 9,185 Rest…
Multiple entities affiliated with KKR, including founding partners Henry R. Kravis and George R. Roberts, have executed a substantial divestment of BrightSpring Health Services, Inc. (NASDAQ: BTSG) common stock. The reported transactions total approximately $857.5 million and occurred on June 5, 2026. This selling activity takes place against a bac…
Paul A Maleh, President and Chief Executive Officer of CRA International, Inc. (NASDAQ:CRAI), executed a series of stock sales totaling 7,500 shares on June 3, 2026, with a combined transaction value of $1,026,244. The sales were carried out under a Rule 10b5-1 trading plan established on November 19, 2025. The transactions occurred across multiple…
Joseph M. Chybowski, serving as President and Chief Financial Officer of Bridgewater Bancshares Inc (NASDAQ:BWB), executed a transaction involving the sale of 7,000 shares on June 5, 2026. The total value of this sale was $132,715. The shares were sold at prices ranging from $18.95 to $19.02 per share. This transaction followed the exercise of opti…
James S. Mahan III, the Chief Executive Officer and a significant shareholder of Live Oak Bancshares, Inc. (NASDAQ: LOB), has executed a series of stock sales totaling approximately $737,302. The transactions, conducted through a Rule 10b5-1 trading plan established in August 2025, involved the liquidation of 20,000 shares across early June 2026. T…
Raja Prabu G., President of the Semiconductor Products Group at Applied Materials Inc. (NASDAQ: AMAT), executed a significant stock sale totaling approximately $25.26 million on June 4, 2026. This transaction involved the disposal of 50,000 shares, with individual share prices ranging from $503.99 to $507.23. The sale occurs against a backdrop of s…
John W. Schlosser, Vice President and President of Terminals at Kinder Morgan, Inc., executed a sale of 6,166 shares of Class P Common Stock on June 5, 2026. The transaction, valued at approximately $196,263, was conducted under a pre-arranged 10b5-1 trading plan established in May 2025. This sale follows a period of robust financial performance fo…
Artur Bergman, Chief Technology Officer of Fastly, Inc. (NASDAQ:FSLY), executed a series of share sales totaling $165,345 on June 3, 2026. The transactions were facilitated through a Rule 10b5-1 trading plan established a year prior and processed via a revocable trust structure. This activity unfolds against a backdrop of significant stock price ap…
Najat Khan, Chief Executive Officer and President of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), completed a transaction involving the sale of 23,588 shares of the company’s Class A Common Stock on June 5, 2026. The sale, valued at $84,459, was executed under the parameters of a Rule 10b5-1 trading plan established by Ms. Khan on September 22, …
AppLovin Corp director Maynard G Webb Jr. executed a significant divestment of 3,076 shares of Class A Common Stock, totaling $1,790,364, on June 5, 2026. The sale, conducted under a pre-arranged Rule 10b5-1 trading plan established in March, coincides with a broader market correction for the company's stock, which has declined nearly 9% over the p…
Christopher Gibson, a director at Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), executed a sale of 40,000 shares of Class A Common Stock on June 5, 2026, totaling $144,800. The transaction, conducted at $3.62 per share, was facilitated through a Rule 10b5-1 trading plan adopted on May 12, 2025. This sale follows a conversion of 40,000 Class B Com…
NetApp, Inc. (NASDAQ: NTAP) Director Gerald Held executed a sale of 7,132 common shares on June 3, 2026, realizing approximately $1.28 million. The transaction follows a 74% surge in NetApp's stock price over the past year, though valuation metrics suggest the shares may be trading above their fair value. Held retains direct ownership of 13,775 sha…
nCino, Inc. (NASDAQ: NCNO) CEO and President Sean Desmond completed a transaction involving the sale of 8,064 common shares on June 3, 2026. The transaction, valued at $131,120, was executed at a price of $16.26 per share. This sale was conducted under a Rule 10b5-1 trading plan that Desmond established on January 6, 2026. Prior to the sale, Desmon…
Thomas M. Stepien, Chief Executive Officer and a director at Amprius Technologies, Inc. (NASDAQ:AMPX), executed a sale of company shares totaling $41,940 on June 4, 2026, according to a filing with the Securities and Exchange Commission. The transaction involved the disposal of 2,000 shares of common stock at a price of $20.97 per share. This sale …
David May, a director at SurgePays, Inc. (NASDAQ:SURG), recently executed a series of share purchases totaling $21,151. The transactions, detailed in a Form 4 filing with the Securities and Exchange Commission, took place over three consecutive days in early June. May acquired 40,250 shares at a fixed price of $0.5255 per share, following a limit o…
